Mizuguchi Hiroyuki, Hatano Masaya, Matsushita Chiyo, Umehara Hayato, Kuroda Wakana, Kitamura Yoshiyuki, Takeda Noriaki, Fukui Hiroyuki
Department of Molecular Pharmacology, Institute of Health-Biosciences, The University of Tokushima Graduate School, Japan.
J Pharmacol Sci. 2008 Dec;108(4):480-6. doi: 10.1254/jphs.08222fp. Epub 2008 Dec 10.
Antihistamines are effective for treatment of seasonal nasal allergy. Recently, prophylactic treatment with antihistamines in patients with pollinosis was reported to be more effective when started before the pollen season. The administration with antihistamines from 2 to 6 weeks before onset of the pollen season is recommended for management of allergic rhinitis in Japan. To determine the reason for the effectiveness of prophylactic treatment with antihistamines, the effects of repeated pre-treatment with antihistamines before provocation with toluene 2,4-diisocyanate (TDI) on their nasal allergy-like behavior and up-regulations of histamine H(1) receptors (H1R) and interleukin (IL)-4 mRNAs in their nasal mucosa were examined. Provocation with TDI induced sneezing and up-regulations of H1R and IL-4 mRNAs in the nasal mucosa of TDI-sensitized rats. Repeated pre-treatments with antihistamines including epinastine, olopatadine, or d-chlorpheniramine for 1 to 5 weeks before provocation with TDI suppressed TDI-induced sneezing and the up-regulations of H1R and IL-4 mRNAs in the nasal mucosa more than their administrations once or for 3 days before TDI provocation. Our data indicate that repeated pre-treatment with antihistamines before provocation with TDI is more effective than their single treatment in reducing nasal allergy-like behavior by causing additional suppression of up-regulations of H1R and IL-4 mRNAs in the nasal mucosa.
抗组胺药对季节性鼻过敏的治疗有效。最近,有报道称,花粉症患者在花粉季节开始前使用抗组胺药进行预防性治疗效果更佳。在日本,建议在花粉季节开始前2至6周使用抗组胺药来治疗变应性鼻炎。为了确定抗组胺药预防性治疗有效的原因,研究了在使用甲苯2,4 -二异氰酸酯(TDI)激发前反复使用抗组胺药预处理对其鼻过敏样行为以及鼻黏膜中组胺H(1)受体(H1R)和白细胞介素(IL)-4 mRNA上调的影响。TDI激发可诱导TDI致敏大鼠打喷嚏,并使鼻黏膜中的H1R和IL-4 mRNA上调。在TDI激发前1至5周,用包括依匹斯汀、奥洛他定或右旋氯苯那敏在内的抗组胺药反复预处理,比在TDI激发前单次给药或给药3天更能抑制TDI诱导的打喷嚏以及鼻黏膜中H1R和IL-4 mRNA的上调。我们的数据表明,在TDI激发前用抗组胺药反复预处理,通过进一步抑制鼻黏膜中H1R和IL-4 mRNA的上调,在减轻鼻过敏样行为方面比单次治疗更有效。